While androgens are both circulating and produced in tissue, elevated tissue DHT, implicated in AGA and benign prostatic hyperplasia, and prostate cancer, as well as AR sensitivity, may be better predictors of COVID-19 severity than circulating androgen levels. This evidence concerns the gene AR and prostate carcinoma.